We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
- Authors
Toomey, Sinead; Eustace, Alex J.; Pritzker, Laura B.; Pritzker, Ken P. H.; Fay, Joanna; O'Grady, Anthony; Cummins, Robert; Grogan, Liam; Kennedy, John; O'Connor, Darran; Young, Leonie; Kay, Elaine W.; O'Donovan, Norma; Gallagher, William M.; Kalachand, Roshni; Crown, John; Hennessy, Bryan T.
- Abstract
A letter to the editor is presented in response to the article "RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy" in the 2015 issue.
- Subjects
RNA; BREAST cancer gene therapy; PHYSIOLOGY
- Publication
JNCI: Journal of the National Cancer Institute, 2016, Vol 108, Issue 8, p1
- ISSN
0027-8874
- Publication type
letter
- DOI
10.1093/jnci/djw111